Your browser doesn't support javascript.
loading
Structure-guided design of anti-cancer ribonucleotide reductase inhibitors.
Misko, Tessianna A; Liu, Yi-Ting; Harris, Michael E; Oleinick, Nancy L; Pink, John; Lee, Hsueh-Yun; Dealwis, Chris G.
Afiliação
  • Misko TA; a Department of Pharmacology, School of Medicine , Case Western Reserve University , Cleveland , OH , USA.
  • Liu YT; b School of Pharmacy, College of Pharmacy , Taipei Medical University , Taipei , Taiwan.
  • Harris ME; c Department of Chemistry , University of Florida , Gainesville , FL , United States.
  • Oleinick NL; d Department of Radiation Oncology, School of Medicine , Case Western Reserve University , Cleveland , OH , USA.
  • Pink J; e Case Comprehensive Cancer Center, School of Medicine , Case Western Reserve University , Cleveland , OH , USA.
  • Lee HY; b School of Pharmacy, College of Pharmacy , Taipei Medical University , Taipei , Taiwan.
  • Dealwis CG; f Ph.D Program in Biotechnology Research and Development, College of Pharmacy , Taipei Medical University , Taipei , Taiwan.
J Enzyme Inhib Med Chem ; 34(1): 438-450, 2019 Dec.
Article em En | MEDLINE | ID: mdl-30734609
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ribonucleotídeo Redutases / Inibidores Enzimáticos / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ribonucleotídeo Redutases / Inibidores Enzimáticos / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article